share_log

Telehealth Market News: Braxia Scientific Enters Industry By Acquiring Ketamine Treatment Platform In Florida

Benzinga Real-time News ·  Aug 3, 2022 14:54

A researcher and provider of ketamine-assisted treatments for mental health conditions,Braxia Scientific Corp. (OTC:BRAXF)has completed the acquisition of the issued and outstanding stock ofU.S.-based, private telemedicine company KetaMD Inc., with the goal of addressing mental health issues by providing access to technology-mediated ketamine treatments.

Founded by psychedelic pioneersZappy ZapolinandWarren Gumpelalong with mindfulness instructorKaia Romanand president and COOLeann Taylor, KetaMD's telemedicine platform works to provide access to safe and affordable at-home ketamine treatments for those suffering from depression and related mental health conditions across...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment